These findings refine our understanding of the mechanism of MELK-induced carcinogenesis and suggest that targeting the MELK/DLAT-mediated mitochondrial pathway may be a potential strategy for treating HCC. The gene discussed is MELK; the disease is hepatocellular carcinoma.